In AML patients, quantitative real-time PCR analysis has suggested the downregulation of selective autophagy marker NBR1 expression along with other autophagy proteins such as LC3, Beclin1, UVRAG, and Rubicon [57]. This evidence concerns the gene MAP1LC3A and acute myeloid leukemia.